Trial
NCT03588741
Evaluation of Safety Following Immune Tolerance Induction Treatment With Turoctocog Alfa in Patients With Haemophilia A Following Inhibitor Development in NN7170-4213 Trial
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Novo Nordisk A/S
Collaborators
—
Condition
Haemophilia A
Intervention
Turoctocog alfa
Why stopped
The trial was terminated as the participant withdrew from the trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-07-07